Wang Tao, UBS: It is expected that the Central Economic Work Conference will focus on the short-term policy package. Recently, the market highly expects the Central Economic Work Conference to guide the high-quality economic development of China next year. Wang Tao, head of Asian economic research at UBS and chief China economist, said: "I expect that the Central Economic Work Conference may focus on the short-term policy package in 2025 and 2026, but it will also emphasize accelerating some reform measures already outlined at the Third Plenary Session." Wang Tao believes that the next important reform measures may include providing better protection and access for the private economy, deepening the reform of state-owned enterprises to improve efficiency and governance, promoting household registration reform to improve the welfare of migrant workers, strengthening the social security network, and carrying out fiscal and taxation reforms to solve local fiscal revenue problems. "I think structural, deeper and faster reforms will be very important, not only to attract foreign investment, but also to boost domestic confidence." (China Daily)Finance Minister of Thailand: The Cabinet approved a reduction of 0.23% in FIDF (Financial Institution Rehabilitation Fund) donations within three years.The commercial chain plate continued to rise, and Zhijia actually had a daily limit in the afternoon. Youa shares and Yimin Group had previously had daily limit, while Doctor Glasses, Commodity City and Chongqing Department Store followed suit.
At midday, the main contract of alumina futures opened lower, and now it is down nearly 3% to 5101 yuan/ton. In the news, according to Shanghai Nonferrous Metals, on December 10th, 30,000 tons of alumina was sold overseas, with a transaction price of $680/mt FOB Western Australia, and the shipping date was in late January/early February.Wuxi factory was completed last year, and Yakult in Shanghai was closed this year: The Shanghai factory has been integrated into the Shanghai headquarters. Recently, the news that Yakult, a lactic acid bacteria brand, closed its Shanghai factory attracted attention. It is reported that the Shanghai factory producing Yakult, a lactic acid bacteria beverage, stopped production on December 6, and the production will be fully transferred to other domestic bases such as Tianjin factory and Wuxi factory. In this regard, Yakult China said that the Shanghai factory has been integrated into the Shanghai headquarters, and the closure of the Shanghai factory is part of the business reform, with the aim of improving production efficiency through restructuring and integrating resource allocation to further improve sales and performance. (21 Finance)India's stock market raised $17.3 billion in new shares this year, ranking first in the world. According to data compiled by KPMG, as of December 8, the Indian National Stock Exchange raised $17.3 billion in new shares, ranking first in the world this year. Followed by the Nasdaq Stock Exchange, raising $16.5 billion. New york Stock Exchange ranked third, raising 15.9 billion US dollars. Hong Kong ranked fourth, raising $10.4 billion, and Shanghai Stock Exchange ranked fifth, raising $8.8 billion.
Australia's S&P/ASX200 index closed down 39.40 points, or 0.47%, at 8353.60 points on Wednesday, December 11th.Some state-owned banks received a notice from the meeting that the personal pension system is expected to be fully opened. On December 11, the reporter learned from people familiar with the matter that some state-owned banks have received a notice from the Ministry of Human Resources and Social Security that a video conference on the full implementation of the personal pension system will be held in the middle of this month. By then, on the basis of the pilot experience in 36 cities or regions, the individual pension system is expected to be fully implemented throughout the country. "Open the gate after the meeting!" The above-mentioned person said. (21st century business herald)Hanyu Pharmaceutical Co., Ltd. signed a strategic cooperation agreement with Longma Technology. Recently, Hanyu Biotechnology (Dali) Co., Ltd., a subsidiary of Hanyu Pharmaceutical Co., Ltd., signed a strategic cooperation agreement with Longma Technology Group. The two sides will cooperate in the medical application of industrial cannabis and drug research and development around drugs and cannabinoids.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14